GlassScriptPhysician profile
Bryan M Zweig
NPI 1124141254
$17,952.63
in general payments reported to CMS, 2019-2025
6 companies · $17K in 2025
The $17K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,318 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Travel and Lodging: $2,095 · Food and Beverage: $1,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,840.00 |
| Travel and Lodging | $2,095.01 |
| Food and Beverage | $1,017.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $16,489.75 | 2025 | Pascal, Evoque |
| Abbott Laboratories | $1,300.26 | 2024 | Amplatzer Amulet |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $103.34 | 2025 | Lifevest |
| Chiesi USA, INC. | $33.55 | 2024-2025 | Cleviprex, Kengreal |
| Bridgebio Pharma, INC. | $25.73 | 2025 | Attruby |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Zweig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.